Johnson & Johnson

Darzalex Faspro
Pharma

J&J angles Darzalex for first move into early-stage myeloma

With a positive phase 3 readout, J&J has filed Darzalex for potential U.S. and EU approvals as the first treatment for smoldering multiple myeloma.
Angus Liu Nov 8, 2024 9:53am
eczema atopic dermatitis Black African American patient skin of color

J&J's Tremya, Lilly's Ebglyss score in new patient groups

Oct 25, 2024 11:00am
GSK

GSK's ADC Blenrep delivers survival win against J&J's Darzalex

Nov 14, 2024 9:24am
Johnson Johnsons Baby Powder

DOJ files motion to derail J&J's Texas two-step talc settlement

Oct 22, 2024 11:40am
Two people sit across from each other at a desk

Activist investor Starboard picks up stake in Kenvue: WSJ

Oct 21, 2024 11:00am
Asia

Lilly, Gilead-Yuhan, Leqembi—Fierce Pharma Asia

Oct 18, 2024 8:20am